Proteome Sciences plc
PMSNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $24 | $23 |
| % Growth | -2.8% | -100% | 5.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 13.7% | 32.8% | 0% | 0% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -31% | -22.6% | 0% | 0% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -69.7% | -48.6% | 0% | 0% |
| EPS Diluted | -0.012 | -0.008 | 0.004 | 0 |
| % Growth | -38.6% | -293% | 2,050% | – |
| Operating Cash Flow | -$0 | -$0 | $4 | $11 |
| Capital Expenditures | -$0 | -$0 | -$2 | -$2 |
| Free Cash Flow | -$0 | -$0 | $2 | $9 |